• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Increased pathogenicity of a reassortant 2009 pandemic H1N1 influenza virus containing an H5N1 hemagglutinin

tetano

Editor, Senior Moderator
JVI Accepts, published online ahead of print on 14 September 2011
J. Virol. doi:10.1128/JVI.05582-11


Increased pathogenicity of a reassortant 2009 pandemic H1N1 influenza virus containing an H5N1 hemagglutinin
Troy D. Cline1, Erik A. Karlsson1, Pamela Freiden1, Bradley J. Seufzer1, Jerold E. Rehg2, Richard J. Webby1, and Stacey Schultz-Cherry1,*

1 Departments of Infectious Diseases
2 Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105

* Corresponding author Dr. Stacey Schultz-Cherry, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, Phone: (901) 595-6629, Fax: (901) 595-3099, Email: stacey.schultz-cherry{at}stjude.org


arrow
ABSTRACT
A novel H1N1 influenza virus emerged in 2009 (pH1N1) to become the first influenza pandemic of the 21st century. This virus is now co-circulating with highly pathogenic H5N1 avian influenza viruses in many parts of the world, raising concerns that a reassortment event may lead to highly pathogenic influenza strains with the capacity to infect humans more readily and cause severe disease. To investigate the virulence of pH1N1-H5N1 reassortant viruses we created pH1N1 (A/California/04/2009) viruses expressing individual genes from an avian H5N1 influenza strain (A/Hong Kong/483/1997). Using several in vitro models of virus replication, we observed increased replication for a reassortant CA/09 virus expressing the hemagglutinin (HA) gene of HK/483 (CA/09-483HA) relative to either parental CA/09 virus or reassortant CA/09 expressing other HK/483 genes. This increased replication correlated with enhanced pathogenicity in infected mice similar to the parental HK/483 strain. Serial passage of the CA/09 parental virus and the CA/09-483HA virus through primary human lung epithelial cells resulted in increased pathogenicity, suggesting that these viruses may easily adapt to humans and become more virulent. In contrast, serial passage attenuated the parental HK/483 virus in vitro, and resulted in slightly reduced morbidity in vivo, suggesting that sustained replication in humans may attenuate H5N1 avian influenza viruses. Together, these data suggest that reassortment between co-circulating human pH1N1 and avian H5N1 influenza strains may result in a virus with the potential for increased pathogenicity in mammals.

http://jvi.asm.org/cgi/content/short/JVI.05582-11v1
 
Back
Top